@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
@techcrunch.com 7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT